CDH1 Gene Mutation Analysis
Located on chromosome number 16, E-cadherin is a calcium ion dependent adhesion molecule and plays a major role in development and maintenance of epithelial cell integrity. Mutations of this gene include insertions, deletions, splice site, nonsense and exonic mutations. Loss of gene expression due to any of above mutations lead to rare but aggressive malignancies like HDGC (Hereditary diffuse gastric cancer) and LBC (Lobular breast cancer), also known as Lobular carcinoma in situ.
Hereditary diffuse gastric cancer (HDGC) is inherited as autosomal dominant condition and affected patients have a marked predisposition for gastric cancer. In contrast to other types of gastric cancer, HDGC presents mostly as a flat surface growth over the lining of stomach. Patients frequently present with pain, nausea, vomiting, dysphagia, anorexia, and weight loss. In later stages patients may present with hepatomegaly, ictrus, ascites, lymphadenopaty and pathological bone fractures. Orofacial cleft has also been documented as a feature of HDGC in several individuals.
Women with this CDH1 mutations are at high risk of developing lobular carcinoma of the breast (LBC). During initial stages LBC may go unnoticed. Later it may present as a thickened area, engorgement, swelling, recently inverted nipples, altered appearance and or texture in the breast. However, invasive lobular carcinoma is less likely to cause a firm or distinct breast mass compared to other variants. Loss of E-cadherin expression is almost exclusively found in lobular breast cancer in comparison to other breast tumors and hence helps in distinguishing lobular breast tumors from others.
E-cadherin mutations are also associated with Blepharo-cheilo-odontic syndrome (characterized by abnormalities of the eyelids, lips, and teeth) and other congenital anomalies like cleft lip and cleft palate. It also seems to be associated with certain types of ovarian, prostate and endometrial cancers.
Asymptomatic individuals with E-CADHERIN mutations should be considered for prophylactic total gastrectomy despite normal endoscopic findings. In contrast, in women at risk for lobular breast cancer, prophylactic mastectomy is not routinely advocated.
- Diagnostic confirmation of Hereditary diffuse gastric cancer
- Screening for familial CDH1 mutation to allow for predictive testing in family members
- Evaluation and diagnosis of lobular breast carcinoma
No reportable variants were identified
Whole blood in EDTA.
Stability
- Room: 3-5 days
- Refrigerated: 7-14 days
- J Med Genet. 2010 Jul;47(7):436-44. [PMID: 20591882]
- Nature. 1998 Mar 26;392(6674):402-5. [PMID: 9537325]
- Fam Cancer. 2016 Apr;15(2):215-9. [PMID: 26759166]
- Gastroenterology. 2001 Dec;121(6):1348-53. [PMID: 11729114]
- JAMA Oncol. 2015 Apr;1(1):23-32. [PMID: 26182300]
- Eur J Surg Oncol. 2005 Apr;31(3):259-64. [PMID: 15780560]